SalaryGuide
AboutPricingBlogFor Employers

Marketing jobs

47 marketing jobs

Boston Scientific logo
5 months ago

Senior Product Manager, Global Downstream Marketing EUS

Boston Scientific

Massachusetts, USA (Hybrid)Full time$107K/yr – $203K/yr
Boston Scientific logo
5 months ago

Segment Marketing Lead, Surgical Endoscopy and National Accounts

Boston Scientific

Marlborough, MA (On-site)Full time$120K/yr – $150K/yr
Boston Scientific logo
5 months ago

Senior Manager, Brand and Reputation Insights

Boston Scientific

Marlborough, MA (Hybrid)Full time$132K/yr – $250K/yr
Boston Scientific logo
5 months ago

Manager, Integrated Marketing Operations

Boston Scientific

Massachusetts, USA (Hybrid)Full time$107K/yr – $203K/yr
Boston Scientific logo
5 months ago

Senior Manager, Omnichannel Marketing (Patient)

Boston Scientific

Massachusetts, USA (Hybrid)Full time$126K/yr – $239K/yr
Boston Scientific logo
5 months ago

Senior Manager, Global Brand Marketing

Boston Scientific

Arden Hills, MN (Hybrid)Full time$132K/yr – $250K/yr
Boston Scientific logo
5 months ago

Market Development Manager (MDM), Bariatric Surgeon

Boston Scientific

Massachusetts, USA (Unknown)Full time$120K/yr – $150K/yr
Previous
123
Next

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

47 jobs
Boston Scientific logo

Senior Product Manager, Global Downstream Marketing EUS

Boston Scientific

Massachusetts, USA (Hybrid)

$107K/yr - $203K/yrIn-houseFull-timeSenior level5+ years exp.
5 months ago
Boston Scientific logo

Segment Marketing Lead, Surgical Endoscopy and National Accounts

Boston Scientific

Marlborough, MA (On-site)

$120K/yr - $150K/yrIn-houseFull-timeSenior level10+ years exp.
5 months ago
Boston Scientific logo

Senior Manager, Brand and Reputation Insights

Boston Scientific

Marlborough, MA (Hybrid)

$132K/yr - $250K/yrIn-houseFull-timeSenior level8+ years exp.
5 months ago
Boston Scientific logo

Manager, Integrated Marketing Operations

Boston Scientific

Massachusetts, USA (Hybrid)

$107K/yr - $203K/yrIn-houseFull-timeMid level8+ years exp.
5 months ago
Boston Scientific logo

Senior Manager, Omnichannel Marketing (Patient)

Boston Scientific

Massachusetts, USA (Hybrid)

$126K/yr - $239K/yrIn-houseFull-timeSenior level8+ years exp.
5 months ago
Boston Scientific logo

Senior Manager, Global Brand Marketing

Boston Scientific

Arden Hills, MN (Hybrid)

$132K/yr - $250K/yrIn-houseFull-timeSenior level8+ years exp.
5 months ago
Boston Scientific logo

Market Development Manager (MDM), Bariatric Surgeon

Boston Scientific

Massachusetts, USA (Unknown)

$120K/yr - $150K/yrIn-houseFull-timeSenior level8+ years exp.
5 months ago
Previous123
Boston Scientific logo
Boston Scientific

Senior Product Manager, Global Downstream Marketing EUS

Massachusetts, USA (Hybrid)

$107K/yr – $203K/yrSenior Level5+ years expFull time

Posted 5 months ago

  • Job
  • Company
  • Salaries
  • People
  • Funding
  • Audience
  • News
  • Links

Job Summary

Drive downstream marketing for the EUS needles portfolio, balancing growth with launches.

  • Must-have: 5+ years in medical device product marketing with global downstream experience.
  • Standout: Leads early-stage launch planning and cross-functional collaboration with KOLs and field teams.

Job Description

Responsibilities

  • Own the overall downstream marketing strategy and execution for the EUS needles portfolio, balancing near-term growth initiatives with future launches.
  • Develop and implement comprehensive global go-to-market plans, including segmentation, targeting, customer engagement, and adoption strategies.
  • Partner closely with early clinical users, KOLs, and field teams to gather insights, document outcomes, and translate them into compelling marketing and training materials.
  • Manage the portfolio’s commercial performance, including tracking key metrics such as revenue, utilization, share, and margin, and developing data-driven recommendations to address business opportunities.
  • Lead the commercial execution of a key early-stage EUS product launch, focused on driving initial market development, identifying and converting early adopters, and establishing clinical and procedural proof points.
  • Translate strategic intent into actionable downstream execution plans to accelerate adoption across prioritized accounts.
  • Develop tools, programs, and evidence-based messaging to support the field organization in engaging key customers and driving adoption.
  • Work cross-functionally with Sales, Training, Professional Education, Clinical, Sales Operations, Supply Chain, Manufacturing and HEMA to deliver cohesive and efficient market execution.
  • Forecast demand and guide commercialization pacing to align supply, resource allocation, and performance targets.
  • Monitor globally for competitive trends, emerging clinical data, and customer sentiment to adapt marketing strategies dynamically.
  • Partner with upstream marketing to inform future portfolio direction and evidence-generation priorities based on early market learnings.
  • Foster strong relationships with clinicians and global Key Opinion Leaders to strengthen advocacy, training pathways, and referral networks.
  • Serve as a role model for cross-functional collaboration, creating alignment in early-stage initiatives with high ambiguity and complexity.
  • May mentor or coach junior marketing team members; contributes to developing best practices for the broader EUS and Endoscopy marketing organization.

Requirements

  • Bachelor’s degree
  • At least 5 years of professional experience, including 3 years of progressive product marketing roles in the medical device industry
  • Willingness and ability to travel up to 40%, including internationally
  • Proven track record of successful commercialization and product launches in medical device industry
  • Global downstream experience (i.e. product management, sales engagement and campaign)
  • Ability to work effectively in a cross-functional, matrix organization

Preferred

  • Deep product marketing experience
  • Clinical understanding of endoscopic procedures and customer value drivers
  • Strategic thinker with a bias for action and innovation
  • Advanced degree (e.g., MBA or Master’s in a related field)
    Boston Scientific logo

    Boston Scientific

    4.1 Glassdoor

    Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions.For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.

    Founded in 2008
    Marlborough, Massachusetts, USA
    52K employees (2,281 in marketing)
    www.bostonscientific.com
    84% recommend to a friend
    92% CEO approval

    Salaries

    Posted range

    $107K/yr – $203K/yr

    Taken straight from the job posting.

    See all Boston Scientific salaries

    Marketing Team

    Marketing Team Size
    1,778 (3% of company)
    Median Career Experience
    18 years
    Median Tenure
    8.6 years
    Marketing Roles Posted (Last 30 Days)
    14

    People

    Marketing Leadership

    Mary Beth Moynihan
    Mary Beth Moynihan
    SVP, Market Access and Chief Marketing Officer
    At the company for 29 years 7 months
    Debra Sanchez
    Debra Sanchez
    Vice President Global Marketing
    At the company for 26 years 7 months
    Brooke Allocco
    Brooke Allocco
    Vice President, Cardiology Marketing and Digital Enablement
    At the company for 21 years 6 months
    Sara Koenck
    Sara Koenck
    Vice President Marketing, Peripheral Vascular
    At the company for 16 years 3 months

    Funding

    Total Funding
    $10B
    Last Raise
    $1.6B
    Post IPO Debt, 1 years ago

    Funding History

    • Feb 2025
      Post IPO Debt • $1.6B
    • Feb 2024
      Post IPO Debt • $2.2B
    • Mar 2022
      Post IPO Debt • $3.3B

    Traffic Signals

    Monthly Visitors
    560.3K
    Monthly Google Ads Budget
    $51.3K
    Traffic Source Mix
    Search
    60%
    Direct
    31.3%
    Referral
    6.1%
    Social
    1.5%
    Paid
    1.1%

    Headcount Trend

    Current headcount: ~51.8K

    Recent News

    Boston Scientific pays high price for new Maple Grove facility
    Dec 5, 2025 • Finance & Commerce
    Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter
    Dec 2, 2025 • Fierce Biotech
    Boston Scientific partners with Epic on data integration
    Nov 21, 2025 • Cardiovascular Business
    Boston Scientific (BSX) Down 5.7% Since Last Earnings Report: Can It Rebound?
    Nov 21, 2025 • Yahoo Finance
    Boston Scientific, Epic collaborate on cardiac diagnostic EHR services
    Nov 19, 2025 • MassDevice
    Boston Scientific, Siemens Healthineers partner on cardiac catheter
    Nov 17, 2025 • MedTech Dive
    What Boston Scientific (BSX)'s Surging Sales and Siemens Partnership Mean for Shareholders
    Nov 15, 2025 • Yahoo Finance
    Siemens Healthineers and Boston Scientific partner on next-generation intracardiac echo for LAAO
    Nov 14, 2025 • Cardiovascular Business
    Boston Scientific Up 7% in a Month: How Should You Play the Stock?
    Nov 14, 2025 • Yahoo Finance
    Boston Scientific has a new tool to help TheraSphere fight cancer
    Nov 12, 2025 • Medical Design & Outsourcing
    Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet
    Nov 11, 2025 • Yahoo Finance
    Boston Scientific (BSX): Evaluating Valuation After Strong Q3 Results and New Product Launches
    Nov 6, 2025 • Yahoo Finance
    Boston Scientific announces upcoming investor conference schedule
    Nov 3, 2025 • PR Newswire
    Boston Scientific announces upcoming investor conference schedule
    Nov 3, 2025 • Yahoo Finance
    Buy Boston Scientific Stock. It’s a Way to Diversify From AI?
    Oct 30, 2025 • Barron's
    Is Boston Scientific’s Rally Justified After Another Year of Double Digit Gains?
    Oct 28, 2025 • Yahoo Finance
    Boston Scientific shares positive Agent drug-coated balloon findings
    Oct 27, 2025 • MassDevice
    Should Boston Scientific’s (BSX) Upbeat Q3 Results and Raised Guidance Prompt Investor Action?
    Oct 24, 2025 • Yahoo Finance
    Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
    Oct 23, 2025 • Yahoo Finance
    Boston Scientific announces agreement to acquire Nalu Medical
    Oct 23, 2025 • NeuroNews International
    Boston Scientific continues to win in electrophysiology
    Oct 22, 2025 • MedTech Dive
    Earnings call transcript: Boston Scientific Q3 2025 beats forecasts, stock climbs
    Oct 22, 2025 • Investing.com
    Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up
    Oct 22, 2025 • Zacks Investment Research
    Acquisitive Boston Scientific sees growth rate ease in Q3
    Oct 22, 2025 • Fierce Biotech
    Boston Scientific lifts annual profit forecast on strong demand for heart devices
    Oct 22, 2025 • Yahoo Finance
    Boston Scientific Makes A Bullish Move After Sales In One Segment Skyrocket 63%
    Oct 22, 2025 • Investor's Business Daily
    Boston Scientific announces results for third quarter 2025
    Oct 22, 2025 • PR Newswire
    Boston Scientific lifts annual profit forecast on strong demand for heart devices
    Oct 22, 2025 • Reuters
    Boston Scientific Raises Outlook on Continued Cardiovascular Growth - WSJ
    Oct 22, 2025 • The Wall Street Journal
    New Boston Scientific Facility Opens in Maple Grove
    Oct 21, 2025 • Twin Cities Business
    Analyst Visit Confirms Growth Potential for Boston Scientific Corporation (BSX), Buy Rating Retained
    Oct 21, 2025 • Yahoo Finance
    Boston Scientific to drop $533M to acquire neurostimulator maker Nalu Medical
    Oct 20, 2025 • Fierce Biotech
    New Boston Scientific facility opens in Maple Grove
    Oct 20, 2025 • kare11.com
    Boston Scientific Celebrates Opening of $170M Maple Grove Campus
    Oct 20, 2025 • CCX Media -
    Boston Scientific opens 400,000-square-foot facility in Maple Grove
    Oct 20, 2025 • CBS News
    Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings
    Oct 20, 2025 • Yahoo Finance
    Latham & Watkins Advises Nalu Medical, Inc. on Acquisition by Boston Scientific
    Oct 20, 2025 • Latham & Watkins LLP
    Boston Scientific (BSX): Assessing Valuation as Shares Post Steady Gains
    Oct 17, 2025 • Yahoo Finance
    Boston Scientific Announces Intent to Acquire Nalu Medical
    Oct 17, 2025 • Newsweek
    Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
    Oct 17, 2025 • PR Newswire
    Boston Scientific to acquire Nalu Medical for $533M
    Oct 17, 2025 • MassDevice
    Boston Scientific boosts chronic pain therapy portfolio with Nalu deal
    Oct 17, 2025 • Reuters
    Boston Scientific to buy Nalu Medical for $533M
    Oct 17, 2025 • MedTech Dive
    Boston Scientific to purchase California medtech for $533M
    Oct 17, 2025 • Worcester Business Journal
    Boston Scientific Dives Into Chronic Pain Through New Acquisition
    Oct 17, 2025 • Medical Device and Diagnostic industry
    Boston Scientific acquires Nalu Medical for $533m
    Oct 17, 2025 • Medical Device Network
    Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth
    Oct 15, 2025 • Yahoo Finance
    Is Boston Scientific’s Share Price Justified After Its Recent 7.6% Monthly Drop in 2025?
    Oct 14, 2025 • Yahoo Finance
    Boston Scientific (BSX) Stock Moves -1.92%: What You Should Know
    Oct 10, 2025 • Yahoo Finance
    Boston Scientific: Not In The Most Resolute State As It Approaches Q3 Earnings
    Oct 9, 2025 • Seeking Alpha
    Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term
    Oct 6, 2025 • Yahoo Finance
    Inside Boston Scientific’s Acquisition Strategy
    Oct 3, 2025 • Medical Device and Diagnostic industry
    Boston Scientific aims for market leadership in electrophysiology
    Oct 2, 2025 • MedTech Dive
    Elutia closes $88M bioenvelope sale to Boston Scientific
    Oct 1, 2025 • Drug Delivery Business
    Boston Scientific unveils plans for new Watchman device
    Oct 1, 2025 • MedTech Dive
    Interventional Cardiology Devices Market to Reach US$39,234.52 million by 2033, at CAGR of 9.0% | Business Market Insights
    Sep 29, 2025 • PR Newswire
    3 Healthcare Stocks Using AI to Drive Growth
    Sep 27, 2025 • MarketBeat
    Renal Stents Market Growth Trends: US$2.08 Billion by 2033, Driven by CKD & Technological Advances | DataM Intelligence
    Sep 26, 2025 • EIN Presswire
    Why this $8-billion money manager likes Boston Scientific and Oracle
    Sep 26, 2025 • Globe and Mail
    More tariffs could hit Minnesota medtech companies
    Sep 25, 2025 • Star Tribune
    Neurostim Pain Devices Market to Reach USD 25,477.3 Million by 2035, Driven by Innovation in Chronic Pain Therapy
    Sep 25, 2025 • EIN Presswire
    Transjugular Intrahepatic Portosystemic Shunt Market to Hit $127.9 Mn, Globally, by 2031 at 3.2% CAGR
    Sep 25, 2025 • EIN Presswire
    Single-use Duodenoscope Market Forecasts and Competitive Strategies Report 2025-2033: Ambu and Boston Scientific Lead with Innovation and Infection-Free Solutions
    Sep 24, 2025 • Research and Markets
    SoCalBio Investor & Partnership Conference to Feature Keynotes from SetPoint CEO Murthy Simhambhatla, PhD, and MedTech Industry Deal-Maker Ray Cohen
    Sep 24, 2025 • SoCalBio
    Johnson & Johnson, Boston Scientific to Headline MEDevice Boston 2025 Keynote Sessions
    Sep 23, 2025 • Yahoo Finance
    With 8.2% CAGR Chronic Total Occlusion Market Size Surges US$ 4.22 billion by 2031 Amid Rising Cardiovascular Disease Burden | The Insight Partners
    Sep 23, 2025 • PR Newswire UK
    Medtech Leader Erica Rogers Joins Ceribell Board of Directors
    Sep 22, 2025 • Ceribell
    Boston Scientific Corporation (BSX) Expands AI-Enhanced Heart Devices With FARAPULSE Approval
    Sep 21, 2025 • Yahoo Finance
    Head of Boston Scientific’s Endoscopy unit is departing
    Sep 19, 2025 • MassDevice
    Top 3 Health Care Stocks That May Explode In September
    Sep 19, 2025 • Benzinga.com
    Boston Scientific Currently Down Nine Consecutive Days, on Pace for Longest Losing Streak Since September 2005 — Data Talk
    Sep 19, 2025 • Morningstar.com
    Boston Scientific Corporation (BSX) Rated as a ‘Buy’ at Needham on IVL Market Opportunity
    Sep 18, 2025 • Yahoo Finance
    Global Gastrointestinal Devices Market to Achieve 7% CAGR Rise with Growing Aging Population 2030
    Sep 18, 2025 • PharmiWeb
    T.Rx Capital Launches $77.5M Fund I to Invest in Bold Sta...
    Sep 18, 2025 • PharmiWeb
    InspireMD Announces the Appointment of Dan Dearen to its Board of Directors
    Sep 18, 2025 • BioSpace
    Moderna co-founder Robert Langer's son launches new VC with $77.5M, backing from dad
    Sep 18, 2025 • FierceBiotech
    Drug Eluting Balloon Catheter Market to Reach USD 9.4 Billion by 2035, Growing at a 18.0% CAGR | Fact.MR Report
    Sep 17, 2025 • EIN Presswire
    InspireMD Announces the Appointment of Dan Dearen to its Board of Directors
    Sep 17, 2025 • InspireMD Inc.
    Connected Health Market is Projected To Reach US$421.5 Billion By 2031 With CAGR of 6.5% During 2025-2031 | The Insight Partners
    Sep 16, 2025 • PR Newswire UK
    Oppenheimer Touts Boston Scientific Corporation (BSX) as the Best Large-Cap MedTech
    Sep 15, 2025 • Yahoo Finance
    FDA updates serious recall alert for Boston Scientific implanted defibrillator leads
    Sep 15, 2025 • Fierce Biotech
    FDA updates on Boston Scientific defibrillation recall related to 16 deaths
    Sep 15, 2025 • MassDevice
    Neuromodulation Market worth US$10.68 billion by 2030 with 9.4% CAGR | MarketsandMarkets™
    Sep 15, 2025 • PR Newswire UK
    Single Incision Laparoscopic Surgery Industry Report: Competitive Landscape and Future Prospects
    Sep 15, 2025 • EIN Presswire
    Neuromodulation Market worth US$10.68 billion by 2030 with 9.4% CAGR | MarketsandMarkets™
    Sep 15, 2025 • PR Newswire
    Reliability Ireland conference to be held in Kilkenny later this month
    Sep 14, 2025 • Irish Examiner
    Update on Alert: Defibrillation Lead Issue from Boston Scientific
    Sep 12, 2025 • fda.gov
    Interventional Neurology Devices Market Poised for Transformative Growth with Rising Stroke & Aneurysm Treatments 2025
    Sep 12, 2025 • EIN Presswire
    Mid-Urethral Sling Manufacturers: PVDF and P4HB Safer Materials versus Polypropylene
    Sep 12, 2025 • EIN Presswire
    Reliability Ireland Conference to Unite Global Experts on the Future of Engineering
    Sep 12, 2025 • Irish Tech News
    Boston Scientific (BSX): Examining Valuation Following Leadership Change and FARAPULSE FDA Rollout
    Sep 11, 2025 • Yahoo Finance
    Boston Scientific issues follow-up notice on Accolade pacemaker software update
    Sep 11, 2025 • MassDevice
    Boston Scientific inks $88M Elutia deal to challenge Medtronic
    Sep 10, 2025 • Yahoo Finance
    Boston Scientific to purchase Elutia’s drug-eluting envelope business for $88M
    Sep 10, 2025 • Cardiovascular Business
    Global Endoscopy Device Market to Double by 2034 Driven by Technological Innovations
    Sep 10, 2025 • EIN Presswire
    Elutia sells drug-eluting bioenvelope tech to Boston Scientific for $88M
    Sep 9, 2025 • Drug Delivery Business
    Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million
    Sep 9, 2025 • Yahoo Finance
    Boston Sci to Challenge Medtronic in Bioenvelope Market
    Sep 9, 2025 • Medical Device and Diagnostic industry
    Elutia announces sale of bioenvelopes business to Boston Scientific for $88M
    Sep 9, 2025 • thefly.com
    Gaithersburg’s Elutia selling key business line to Boston Scientific, sets sights on new products
    Sep 9, 2025 • Seattle TechFlash

    Links

    www.bostonscientific.comLinkedInX (Twitter)Crunchbase